NewsLife Sciences
GE Healthcare to Present hESC Derived Cardiomyocytes for Drug Safety Testing at Society of Toxicology Meeting 2011
28 Feb 2011Sarah Sarah
Marketing / Sales
Product news
Cardiomyocytes derived from human embryonic stem cells (hESC) on an industrial scale provide an advance towards more clinically predictive assays for assessing cardiotoxicity of new drugs. Data will be presented from high-content imaging and electrophysiological analysis of hESC derived cardiomyocytes illustrating a powerful complimentary and comprehensive approach to assessing cardiac drug liabilities.
March 9, 2011 1:00 – 2:00 pm
Presented by: Nick Thomas, Principal Scientist.
Visit booth 1308 for more information.
Links
Tags
Cell Lines Stem Cells and Primary CellsPrimary cell cultures, established cell lines and stem cells are vital for <i>in vitro</i> and <i>ex vivo</i> experimentation. High-quality cells, optimized for your applications, alongside optimized cell substrates, growth medium and supplements, are critical for experimental success. Explore a range of cells suitable for your applications, including isogenic cell lines, competent cells, induced pluripotent stem cell (iPSC)-derived cell lines, fungal/bacterial/mammalian cell lines, stem cells and cancer cell lines. Find the best cells for your research in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.ADME-ToxicologyADME-toxicology (ADME-Tox) studies are used in pharmacology and pharmacokinetics to assess the activity/toxicity of drugs <i>in vivo</i> or <i>in vitro</i>. Find bioassays for absorption, distribution, metabolism, and excretion of drug molecules including cytotoxicity, transporter/permeability, metabolism and activity assays as well as hepatocytes and cell lines for ADME. Find the best ADME-toxicology products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.